ACM
TMO icon

Arvin Capital Management’s Thermo Fisher Scientific TMO Stock Holding History

Arvin Capital Management’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$24.6M Buy
+50,000
New +$27.1M 3% 9
2025
Q4 		– Sell
-18,000
Closed -$8.73M – 50
2025
Q3 		$8.73M Buy
18,000
+6,000
+50% +$2.79M 1.58% 27
2025
Q2 		$4.87M Buy
+12,000
New +$5.02M 1% 32

Other funds holding TMO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Arvin Capital Management's TMO Position: Q1 2026 in Review

Arvin Capital Management increased its Thermo Fisher Scientific (TMO) stake by 65% in Q1 2026, buying an estimated $23.8M and bringing the position to 111,697 shares worth $54.9M. The position accounts for 6.7% of the portfolio, ranked #3.

Arvin Capital Management first reported a position in TMO in Q4 2023 and has held it in 5 quarters since. 2,589 funds tracked by Wall St. Rank hold TMO as of Q1 2026.

  • Arvin Capital Management held 111,697 shares of Thermo Fisher Scientific worth $54.9M as of Q1 2026.
  • Arvin Capital Management bought 43,897 Thermo Fisher Scientific shares in Q1 2026, an estimated $23.8M.
  • Thermo Fisher Scientific made up 6.7% of Arvin Capital Management's portfolio in Q1 2026, its #3 holding.
  • Arvin Capital Management first reported a position in Thermo Fisher Scientific in Q4 2023 and has held it in 5 quarters since.
  • 2,589 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.

Based on Arvin Capital Management's 13F filing for Q1 2026, filed 14 May 2026.